Merck Careers - Search News

Merck to buy rights to Chinese cancer drug

Merck Snags Chinese Cancer Drug in Deal Worth Up to $3.3 Billion

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront, plus as much as $2.7 billion in milestone payments.

Seeking Alpha · 9h

Merck to buy rights to Chinese cancer drug for up to $3.3B

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate called LM-299 from LaNova. Read more here.

Reuters on MSN · 9h

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and sell an experimental cancer drug, the two companies said on Thursday. The deal allows Merck to take over development of LaNova's LM-299,

STAT · 6h

Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company

STAT2d

RNA startup Orna Therapeutics cuts more jobs

Orna Therapeutics, part of a buzzy cohort of biotech companies established in the wake of the Covid pandemic, has cut more ...

Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

16d

Life science business investing $76M, adding 170 jobs at St. Louis facility

Based outside Boston, MilliporeSigma was formed after Merck KGaA acquired St. Louis-based Sigma-Aldrich Corp. for $17 billion ...

Ad Age17d

Merck—ad spending, facts and profile

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

7don MSN

Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Morningstar1d

Merck & Co Inc MRK

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bloomberg L.P.27d

Why This Pharma Boss Isn’t Chasing the Obesity Hype

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, the shares have ...

Hosted on MSN27d

Merck's RSV Shot Cuts Infant Hospitalizations by Over 80% in Trial, Eyes 2025 Launch

Merck reported positive results for its experimental treatment ... That changed with ‘Super/Man: The Christopher Reeve Story’ Terry Bradshaw's new career switch announced live on FOX amid ongoing ...

heraldscotland29d

Merck to invest millions in expansion of Livingston facility

German pharma and technology giant Merck has announced a €5 million (£4.2m) investment in Scotland that will create further jobs at its diagnostics and blood typing facility in Livingston.

Wall Street Journal28d

Merck KGaA Shares Jump on Expectations of AI Boost

Merck KGaA’sMRK-1.94%decrease; red down pointing triangle shares jumped after the German company said booming artificial-intelligence demand would help its electronics sales grow faster than ...

8hon MSN

Merck KGaA continues focus on strengthening pipeline with external innovation, says CFO on drug trials

Merck KGaA CFO Helene von Roeder discusses the group's third-quarter earnings and its progress with drug trials.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results